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a  b  s  t  r  a  c  t
Deep  learning  (DL)  is a family  of machine  learning  methods  that  has  gained  considerable  attention  in
the  scientiﬁc  community,  breaking  benchmark  records  in areas  such  as  speech  and  visual  recognition.  DL
differs from  conventional  machine  learning  methods  by virtue  of its  ability  to  learn  the  optimal  represen-
tation  from  the  raw  data  through  consecutive  nonlinear  transformations,  achieving  increasingly  higher
levels  of  abstraction  and  complexity.  Given  its ability  to detect abstract  and  complex  patterns,  DL has
been  applied  in  neuroimaging  studies  of  psychiatric  and neurological  disorders,  which  are  characterised
by  subtle  and  diffuse  alterations.  Here  we introduce  the  underlying  concepts  of DL and  review  studies
that  have  used  this  approach  to  classify  brain-based  disorders.  The  results  of these  studies  indicate  that
DL  could  be a powerful  tool  in  the current  search  for biomarkers  of  psychiatric  and  neurologic  disease.  We
conclude our  review  by  discussing  the  main  promises  and  challenges  of  using  DL  to elucidate  brain-based
disorders,  as  well  as possible  directions  for  future  research.
©  2017  The  Authors.  Published  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
Contents
1. Introduction  . .  .  . . .  . .  .  . . .  . . . .  . . . .  . . . .  . . .  .  . . .  .  . . .  .  . . . .  . . .  . . . .  . . .  . . . . .  . .  . . . . .  . .  .  . . . .  . .  .  . . . . . .  .  . . . . . .  .  . . . . . . .  . . . .  .  . .  . .  .  .  .  . . .  . .  .  .  . . .  . .  . .  .  .  .  .  .  .  . .  . . . . .  . . . .  .  .  .  .  .  59
2.  Overview  . .  .  . .  .  . . .  .  .  . . .  .  . . .  .  . . .  .  . . .  .  . . . . . .  . . . .  . . .  .  . . .  .  . . .  .  .  . .  . . .  .  . . .  . . .  .  .  . . . . . . . .  . .  . . . . .  . . . . . .  . . .  . . . . .  . . .  .  .  . . . .  .  . . . . . . .  .  . . . .  . .  .  . . .  . . . . . .  . . . .  . .  .  .  . .  . .  . . . . .  60
2.1. Multilayer  perceptron  .  . . . .  . . . .  . . . .  . . .  .  . . . .  . . . .  . . .  . . . .  . . .  .  . . . . . .  . . . . .  . .  .  . . . . . . .  . .  . . . . . . . . . . .  . . . .  . . . . . . .  . .  . . . . .  .  . . . . . .  .  .  . . . . .  .  . . . .  .  .  . . . . .  . . .  . .  . . . .  60
2.1.1.  Network  structure  . . . .  . . .  .  . . .  .  . . .  .  . . .  . . . .  . . .  . . . . .  . .  . . . . .  . . . .  . . .  .  . .  . . . . . . .  .  . . . . . .  . . . .  . . .  . .  . . .  . . . . .  . .  . . .  . . . . . . . .  .  .  . . . . .  .  . . .  .  .  . . . .  .  . . . .  .  . . 60
2.1.2. Training  .  .  .  . . . . . . .  . . . . . . .  . . .  .  . . . .  . . . .  .  . .  . . . .  .  . .  .  . . . . . .  .  .  . . .  .  . .  .  . . . . . . . . . . . .  . . .  . . . . . . . .  . . . . .  . .  .  . . . .  .  . .  . . . . . .  . . . . .  . .  . .  .  . .  . . .  .  . . .  .  . .  .  .  . .  . . .  60
2.1.3.  Testing  . . .  . . . . .  . . . . . .  . . .  .  . . .  .  . . . .  . . . .  . . . . . . .  . . .  . . . . . . .  .  . . . . . . .  . . .  . .  .  . . .  . . . .  . . .  . . .  . . .  .  .  . .  . . .  . . .  . . . . .  . .  . . . . .  .  . . . . .  . .  .  . .  .  . . . .  . . . .  .  .  .  .  .  . .  .  .  .  61
2.1.4.  Risk  of  overﬁtting  and  possible  strategies  .  . . .  .  . .  .  .  . . .  . .  . . . . . .  . .  .  . . .  .  . . .  . . . . .  .  . . . .  .  . .  . .  . . .  . . .  . . .  . . .  .  .  . . .  . . . . . .  .  . . . .  . .  .  . .  .  . . . .  . . .  . .  .  . .  .  61
2.2.  Autoencoders  .  .  . . .  .  . . . .  . . .  .  . . .  . . .  . . . .  . . . . . . . . . . .  .  . . .  .  . . . . . . .  . . . . . . .  . . . . . .  . . .  . . . . . .  . . . .  .  . .  .  .  .  . .  . . .  .  .  . . . . . .  . . . . . . . .  . . . .  .  . .  .  .  .  . . . .  .  . . . .  .  . .  .  . .  .  . . .  .  . .  63
2.3. Deep belief  networks  . . .  . . .  .  . . .  . . . .  . . .  .  . . .  .  . . .  . . . .  .  . . .  . . . .  . . .  .  .  . .  . . .  .  . . . . . .  . . .  . . . . . . .  .  . . . . .  .  . . . . . .  .  . . . . .  . . .  . . . .  . . .  .  . . . . .  .  .  . . .  . . . . . .  . . . . . . .  . .  . . . . . 63
2.4.  Convolutional  neural  networks  . . . .  .  . . .  .  .  . .  .  . . .  .  . . .  . . .  .  . . . . . . .  . . . . . . .  . . .  .  .  . . .  . . . . . . . . . .  . . . . .  . . .  . . .  . .  .  . . . .  .  . .  . . . . . . .  . . . .  . . . . .  .  . .  . .  .  .  . .  . . . .  . .  .  . .  . . 63
3. Review  of DL  studies  of psychiatric  or neurological  disorders  . .  .  . . . . . .  .  . .  .  . . . .  . . .  . . . . . .  . . . .  . . . . .  . . .  . . . . .  .  .  . . .  . . .  . . . . .  . .  .  . . .  .  .  . . .  .  .  . . . .  .  . . . .  . . .  . . .  . .  .  .  .  63
3.1.  Diagnostic  studies  . . . .  .  . . .  .  . .  .  .  . .  . . . .  . . .  . . . .  .  . . .  .  . . .  . .  . .  . . .  . . .  .  . . .  . .  . . . . . . . . . . . . .  . . .  . . .  . . . . .  . . . . .  . .  . . . . . . .  .  . . . . . .  .  . . . . . .  .  . .  .  .  .  .  . . . . . . . . . . . .  .  .  .  .  .  . 65
3.1.1. Mild  Cognitive  Impairment  and  Alzheimer  Dementia  . . . . .  .  .  .  .  . . . .  . . .  . . .  . . .  .  . . .  . . .  . . . . .  . . . . . . . .  . .  .  . . .  . . . .  . . . . . . . .  .  . . . . . . . . . .  . .  . .  .  .  . .  .  65
3.1.2.  Attention-deﬁcit/hyperactive  disorder  . . .  . . . .  . . . . . . .  .  . . . .  . . .  .  . .  . . . . . .  . . . . . . .  .  . . . .  . .  .  . . . . . .  .  . . . .  . . .  .  . . . . . . . .  .  .  . .  .  .  .  . . . . .  . . . . .  . . .  .  . .  . . .  67
3.1.3.  Psychosis .  . .  .  . . . .  . . .  .  . . .  . . . .  . . .  .  . . .  .  . .  .  .  . .  .  . . .  .  . . .  . . .  .  . . . .  . .  .  .  .  .  . . . .  . .  .  . . . . . .  . . . . . . .  .  . . . .  . . . . .  . . .  . .  . . . .  .  . . .  .  . .  .  . . . .  .  .  .  .  . . . .  . . . . . .  . . .  .  . .  .68
3.1.4.  Temporal  lobe  epilepsy  .  .  . . . .  . . . . . .  .  . . .  . . .  .  . . . . . . .  . . . .  . . .  .  . .  .  .  . . . . .  . .  .  . . . .  . . . . . . .  .  . .  . . .  .  .  . . . . . .  .  . . . . . . .  . . . .  . . .  .  .  .  .  .  .  . . . . . . . . . .  . .  .  . .  .  . .  . 68
∗ Corresponding author.
E-mail address: sandra.vieira@kcl.ac.uk (S. Vieira).
http://dx.doi.org/10.1016/j.neubiorev.2017.01.002
0149-7634/© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
S. Vieira et al. / Neuroscience and Biobehavioral Reviews 74 (2017) 58–75 59
3.1.5.  Cerebellar  ataxia  .  . . . .  . . . . . .  .  . . .  .  . . .  .  .  . .  .  . . .  .  . .  .  . . . .  .  .  . . .  .  . .  .  . . . . .  .  . . . . . .  . . .  . . . .  .  . . .  .  .  . . . . .  . .  . . .  . .  .  . . . . .  . . . . .  . .  . . .  .  . . . . . .  . . .  .  . . .  . .  .  . . .  . . 68
3.2.  Conversion  to illness  .  . . . .  . . . .  . . .  .  . . .  .  . . .  .  .  . .  .  .  . .  .  . . .  .  . .  . . . .  . . . . . . .  .  . .  . . . . . . . .  . . . . . . .  .  . . . .  .  . .  . . . .  . . .  .  . . .  . . . .  . . . . . . .  . . . . . . . . .  . . .  .  .  .  .  . .  . .  . . . .  . . .  .  .  .  68
3.2.1.  From  Mild  Cognitive  Impairment  to Alzheimer  Dementia  .  . . . . . .  .  .  . . . .  .  .  . . . . . .  .  . . . .  .  . . .  .  . . .  . . . .  .  . . . .  . . . . . . .  . .  . .  .  . . .  .  . . . . .  .  . . .  . .  .  .  .  .  . 68
3.3.  Treatment  outcome  .  .  . . . . . .  . . . .  . . .  .  . . .  . . .  .  . . .  . . . .  . . . . . . .  . . . .  .  . .  . . . . . . . . . .  . . . . . .  .  . . .  . . . . .  . . . . .  .  . . .  . . . .  . . . . . . .  . . . . . . . .  .  . . . . .  .  .  .  .  . .  . . .  . . . . . . .  . . . . . . 69
3.4.  How  does  DL  compare  to a  traditional  machine  learning  approach?  .  . . . . .  . . .  .  .  . . . . . .  .  .  . . .  . .  .  . . . .  .  . .  .  . . . . . .  . . . .  .  . .  .  .  .  . . .  .  . . . . .  . .  . .  . .  .  .  . .  .  . .  . . .  69
4. Discussion  . .  . . . .  . .  .  . .  .  . . .  .  . . .  .  . . .  .  . . . .  . . . . . .  .  . .  .  .  . .  .  .  . .  .  .  . . . . . . .  . .  . . . .  .  . . . . . . .  . . .  . .  .  . . . .  . .  . . .  . .  . .  .  . . .  . . . . . . .  .  . .  .  . . .  .  . . .  . . . .  .  . . . . . .  .  . .  .  . .  . . .  .  . . . . . . .  . . . . . .  69
4.1.  Main  conclusions  from  the  existing  literature  . .  .  . . .  .  . . . . . . .  . .  . . . . .  . .  .  . .  .  . .  . . . . . . .  . . . . .  . . .  . . .  . . .  . . . .  .  . . . . .  . . . . .  . . .  .  . . . . . .  .  . . . .  .  .  .  .  . .  .  . . . . .  . . . . .  . 70
4.2.  The  promise  of  convolutional  neural  networks.  .  .  .  . .  . . .  .  . .  . . . . .  .  .  .  . . .  . . . .  . . .  . .  .  . . . . . . .  . . . . .  . . .  . . . . . . . .  . .  .  . . . .  .  . . . .  .  . . . .  .  .  .  . . .  .  . . .  . . .  . . .  .  . . .  . . . .71
4.3.  From  binary  to  multiclass  classiﬁcations  . . .  .  . . .  . . . .  . . .  . . .  .  . . . .  .  . .  .  . . . .  . .  . . . .  . .  .  .  . . .  . .  .  . . . .  . . .  .  .  . . .  . . .  .  .  . . . . .  .  .  .  .  . . .  .  .  .  .  .  . . .  .  . . . . . .  . . .  .  . .  .  .  .  .  . . . 71
4.4.  Is  deep learning  superior  to conventional  machine  learning?  . . . .  . . .  . . . . .  .  . . .  . . . .  .  . . . . . . .  . .  . . . .  .  . . .  . . .  . .  .  . . . .  . . . . . .  . .  . . .  . .  .  . .  .  . . . . . .  .  . .  .  . . .  . .  . 71
4.5.  Interpretability  of DL  in  neuroimaging  . .  .  .  .  . .  .  . . .  .  . . . . . .  .  . . . . . . .  . . .  .  . . . . .  .  . .  . . . . .  . . . . .  . .  .  . . . . . .  .  . . . . . . .  . . . . . . .  . . . . . . . . .  .  . . .  .  .  .  . . .  .  . . . . . .  . .  . . . . .  72
4.6.  The  challenge  of  overﬁtting  . . . .  . . .  .  . . .  . . . .  . . . . . . . .  .  . . . . . . . . . .  . . . .  . . .  . . .  . . .  . . . . . .  . . . . . . .  .  .  . . .  .  . . . .  . .  . . .  . .  . . .  . . . .  .  .  . . . . .  . . . . . .  .  . .  .  . .  . . .  . . . .  . . .  .  . .  . 72
4.7. Technical  expertise  and  computational  requirements  .  . . . .  . . . . . . .  .  . .  . . . .  .  . . . . .  . . .  . . . . . . . .  . .  . . . .  .  .  . .  . . .  . .  . . . . .  .  .  . . . . . . .  . .  .  . . .  .  . . . .  .  . .  .  .  . . .  .  .  .  . .  73
5.  Conclusions  and  future  directions  . . .  . . . . . . .  . . . .  . . . .  .  . . .  . . . .  . . .  . . .  .  . . . . . . .  .  . . . . . .  . . .  . . . . .  . . .  . .  .  . . .  .  . . .  . .  . . .  . . . .  .  . . .  . . . . .  . . .  . .  . . . . .  . .  .  .  .  .  . . . .  .  . . . . .  . . .  . . . 73
Acknowledgements .  . . .  .  . . .  .  . . .  . . .  . . . .  . . .  .  . . .  .  . . .  .  .  . . . . . .  .  . . . . . .  .  . . .  . . . . . . .  . . .  . . .  . . .  . . .  .  .  . . . . .  .  . . . .  . . .  . . . . .  . . . .  . . .  . . .  .  . . . . .  .  .  . .  .  . . . . . .  .  . .  .  .  .  . . . . . .  . .  . .  . .73
References  . . .  . . .  . .  . . . . .  . . . . . . .  . . .  . . .  .  . . .  .  . . .  . . . . . . . . . . . . . . .  . . .  . .  . .  .  . . . .  . . .  . . . . . . . . . . . . .  . . .  . . . . .  . . . . .  . . . . .  . . .  .  . . . .  . . .  . . .  . .  . .  .  . . . .  . . .  .  .  .  . . . .  .  . . . . .  . . . . .  . . . 73
1. Introduction
In the last two decades, neuroimaging studies of psychiatric
and neurological patients have relied on mass-univariate ana-
lytical techniques (e.g. statistical parametric mapping). These
studies typically compared patients with a diagnosis of interest
against disease-free individuals and reported neuroanatomical or
neurofunctional differences at group level. The simplicity and inter-
pretability of this approach have led to signiﬁcant advances in our
understanding of the neurobiology of psychiatric and neurological
disorders. Mass-univariate analytical techniques, however, suffer
from at least two signiﬁcant limitations. First, statistical inferences
are drawn from multiple independent comparisons (i.e. one for
each voxel) based on the assumption that different brain regions
act independently. This assumption, however, is not in line with our
current understanding of brain function in health and disease (Fox
et al., 2005; Biswal et al., 2010); for example, several psychiatric
and neurological symptoms are best explained by network-level
changes in structure and function rather than focal alternations
(Mulders et al., 2015; Kennedy and Courchesne, 2008; Shefﬁeld
and Barch, 2016). Second, mass-univariate techniques can be used
to detect differences between groups but do not allow statistical
inferences at the level of the individual. In contrast, a clinician has
to make diagnostic and treatment decisions about the person in
front of them. These two limitations may  have contributed to the
limited translational impact of neuroimaging ﬁndings in everyday
clinical practice so far.
In an attempt to overcome these limitations, the neuroimaging
community has developed a growing interest in machine learning
(ML), an area of artiﬁcial intelligence that aims to develop algo-
rithms that discover trends and patterns in existing data and use
this information to make predictions on new data. This is achieved
through the use of computational statistics and mathematical opti-
mization (Hastie et al., 2001). ML  methods are multivariate and
therefore take the inter-correlation between voxels into account,
thereby overcoming the ﬁrst limitation of mass-univariate analyti-
cal techniques. In addition, ML  methods allow statistical inferences
at single subject level and therefore could be used to inform diag-
nostic and prognostic decisions of individual patients, thereby
overcoming the second limitation of mass-univariate analytical
techniques (Arbabshirani et al., 2016). ML  methods can be divided
into two broad categories: supervised and unsupervised learning.
In supervised ML,  one seeks to develop a function which maps two
or more sets of observations to predeﬁned categories or values. In
contrast, unsupervised methods seek to determine how the data are
organized without using any a priori information supplied by the
operator; here the main objective is to discover unknown structure
in the data (Hastie et al., 2001).
Over the past decade, several ML  methods have been applied to
neuroimaging data from psychiatric and neurological patients with
varying degrees of success (Arbabshirani et al., 2016; Wolfers et al.,
2015). The most popular amongst these methods is Support Vector
Machine (SVM), a supervised technique that works by estimating
an optimal hyperplane that best separates two classes. When these
classes are not linearly separable, SVM uses external functions (ker-
nels) that map  the original data into a new feature space where
the data become linearly separable (Pereira et al., 2009; Vapnik,
1995). Despite its popularity, SVM has been criticised for not per-
forming well on raw data and requiring the expert use of design
techniques to extract the less redundant and more informative fea-
tures (a step known as “feature selection”) (LeCun et al., 2015; Plis
et al., 2014). These features, rather than the original data, are then
used for classiﬁcation. While SVM remains a very popular technique
within the neuroimaging community, an alternative family of ML
methods known as deep learning (DL) (Bengio, 2009) is gaining con-
siderable attention in the wider scientiﬁc community (Arbabshirani
et al., 2016; Calhoun and Sui, 2016; LeCun et al., 2015). Deep learn-
ing methods are a type of representation-learning methods, which
means that they can automatically identify the optimal represen-
tation from the raw data without requiring prior feature selection.
This is achieved through the use of a hierarchical structure with
different levels of complexity, which involves the application of
consecutive nonlinear transformations to the raw data. These trans-
formations result in increasingly higher levels of abstraction, where
higher-level features are more invariant to the noise present in the
input data than lower level ones (LeCun et al., 2015). Inspired by
how the human brain processes information, the building blocks of
DL neural networks − known as “artiﬁcial neurons” − are loosely
modelled after biological neurons. Artiﬁcial neurons are organized
in layers. A deep neural network consists of an input layer, two or
more hidden layers and an output layer. The input layer comprises
the data inputted into the model (e.g. voxel intensity); the hidden
layers learn and store increasingly more abstract features of the
data; these features are then fed to the output layer that assigns
the observations to classes (e.g. controls vs. patients). Learning is
achieved through an iterative process of adjustment of the inter-
connections between the artiﬁcial neurons within the network,
much like in the human brain (Bengio, 2009). An essential aspect
of DL that differentiates it from other ML  methods is that the fea-
tures are not manually engineered; instead, they are learned from
the data, resulting in a more objective and less bias-prone process.
Besides, the ability to achieve higher orders of abstraction and com-
plexity relative to other ML  methods such as SVM makes DL better
suited for detecting complex, scattered and subtle patterns in the
data (Plis et al., 2014).
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From a historical perspective, the use of DL in scientiﬁc research
can be traced back to the perceptron (i.e. the original version
of the artiﬁcial neuron), which many researchers refer to as the
ﬁrst ML  algorithm (McCulloch and Pitts, 1943). After several set-
backs, the pioneering work of Warren McCulloch and Walter Pitts
resulted in the development of what is now known as artiﬁcial
neural networks. However, such networks were able to handle a
limited number of hidden layers. It was only in the 2000s that
researchers developed a new approach for training artiﬁcial neu-
ral networks that allowed the inclusion of several hidden layers
resulting in greater levels of complexity (Hinton et al., 2006).
This breakthrough led to the development of a new family of ML
methods − known as deep learning − which has been shown to out-
perform previous state-of-the-art classiﬁcation methods in areas
such as speech recognition, computer vision and natural language
processing (Krizhevsky et al., 2012; Le et al., 2012).
The use of DL could be particularly useful in the investigation
of psychiatric and neurological disorders, which tend to be associ-
ated with subtle and diffuse neuroanatomical and neurofunctional
abnormalities. Since high-level features can be more robust against
noise in the input data, deep architectures may  be more suitable to
identify diagnostic and prognostic biomarkers than conventional
ML methods. DL techniques might also provide an ideal tool to
investigate the multi-faceted nature of psychiatric and neurologi-
cal disorders since cross-modality relationships (e.g. neuroimaging
and genetics) are likely to occur at an even deeper level (Plis et al.,
2014). In addition to these conceptual differences, the use of DL to
investigate psychiatric and neurological disorders has the practical
advantage of not requiring manual feature selection (LeCun et al.,
2015). Therefore, it is unsurprising that an increasing number of
neuroimaging studies are using DL to elucidate the neural corre-
lates of these disorders (e.g. Payan and Montana, 2015; Plis et al.,
2014; Kim et al., 2016).
Given the insurgence of interest in DL within the ﬁeld of neu-
roimaging, this review aims to give a brief overview of DL and
potential applications to the investigation of brain-based disorders.
In the ﬁrst part of the review, we outline the underlying concepts
of DL. To achieve this, we will use one of the simplest DL structures,
i.e. the multilayer perceptron, to illustrate the steps of training and
testing. This will be followed by a brief description of the most
common DL architectures used in the ﬁeld of neuroimaging, includ-
ing stacked autoencoders, deep belief networks and convolutional
neural networks. The second part of this article aims to summarise
the studies that have applied DL to neuroimaging data to inves-
tigate psychiatric and neurological disorders. Finally, in the third
part of the review, we discuss the main themes that have emerged
from our review of the existing literature, and make a number of
suggestions for future research directions.
2. Overview
Deep learning refers to the training and testing of multi-layered
neural networks that are capable of learning complex structures
and achieve high levels of abstraction. There are two  main types
of DL models which differ with respect to how the information
is propagated through the network. In feedforward networks, the
information is propagated through the network in just one direc-
tion, from the input to the output layer. Recurrent networks, in
contrast, contain feedback connections that allow the information
from past inputs to affect the current output. These connections
enable the information to persist within the neural network, akin to
a form of memory, and this allows the models to process sequential
data, such as speech and language, in a natural way.
The implementation of DL in the context of supervised classi-
ﬁcation problems involves two main steps. In the ﬁrst step, the
so-called training phase,  a subset of the available data known as
the training set is used to optimize the network’s parameters to
perform the desired task (classiﬁcation). In the second step, the so-
called testing phase, the remainder subset which is known as the test
set is used to assess whether the trained model can blind-predict
the class of new observations. When the amount of available data
is limited, it is also possible to run the training and testing phases
several times on different training and test splits of the original
data and then estimate the average performance of the model − an
approach known as cross-validation. The two phases of training and
testing are not a speciﬁc feature of DL but are used in conventional
ML methods.
In this section, we will discuss the use of feedforward DL for
classiﬁcation problems. We  will start with the multilayer percep-
tron (MLP), the simplest deep neural network (DNN) architecture,
to illustrate three important aspects of deep learning − network
structure, training and testing. We  will then describe more com-
plex networks, including stacked autoencoders and deep belief
networks. Finally, we  will describe the increasingly popular con-
volutional neural networks (CNN), an important adaptation of the
MLP  that has come to be considered the state-of-the-art for com-
puter vision.
2.1. Multilayer perceptron
2.1.1. Network structure
MLPs are organized in a layer-wise structure where each layer
stores increasingly more abstract representations of the data
(Fig. 1). The ﬁrst layer is the input layer where the data is entered
into the model. In neuroimaging, the data can be represented as
a one-dimensional vector with each value corresponding to the
intensity of one voxel. The last layer is the output layer which, in
the context of classiﬁcation, yields the probability of a given sub-
ject belonging to one group or the other. The layers between the
input and output layers are called hidden layers, with the number
of hidden layers representing the depth of the network. Each layer
comprises a set of artiﬁcial neurons or “nodes” (Fig. 1a) in which
each neuron is fully connected to all neurons in the previous layer
(Fig. 1b). Each connection is associated with a weight value, which
reﬂects the strength and direction (excitatory or inhibitory) of each
neuron input, much like a synapse between two biological neurons.
Unlike SVM, which relies on expert designed transformations
to handle nonlinearly separable classes, the structure of neural
networks itself allows the transformation of the input space. The
consecutive layers perform a cascade of nonlinear transformations
that distort the input space allowing the data to become more easily
separable (Fig. 2). The optimal number of layers and nodes within
each layer are not estimated as part of the learning process itself but
are deﬁned a priori. These a priori parameters, which are not opti-
mized during the training, are called hyperparameters. It should be
noted that the development of algorithms to ﬁnd optimum values
of these hyperparameters is an active area of research, and that at
present there are no ﬁxed rules (Bergstra et al., 2011; Gelbart et al.,
2014).
2.1.2. Training
Traditionally, neural networks can learn through a gradient
descent-based algorithm. The gradient descent algorithm aims to
ﬁnd the values of the network weights that best minimise the error
(difference) between the estimated and true outputs. Since MLPs
can have several layers, in order to adjust all the weights along the
hidden layers, it is necessary to propagate this error backward (from
the output to the input layer). This propagation procedure is called
backpropagation, and allows the network to estimate how much
the weights from the lower layers need to be changed by the gradi-
ent descent algorithm. Initially, when a neural network is trained,
S. Vieira et al. / Neuroscience and Biobehavioral Reviews 74 (2017) 58–75 61
(a)
(b)
Fig. 1. (a) The building block of deep neural networks − artiﬁcial neuron or node.
Each input xi has an associated weight wi . The sum of all weighted inputs, xiwi ,
is  then passed through a nonlinear activation function f, to transform the pre-
activation level of the neuron to an output yj . For simplicity, the bias terms have
been omitted. The output yj then serves as input to a node in the next layer. Sev-
eral  activation functions are available, which differ with respect to how they map
a  pre-activation level to an output value. The most commonly activation functions
used are the rectiﬁer function (where neurons that use it are called rectiﬁed linear
unit (ReLU)), the hyperbolic tangent function, the sigmoid function and the soft-
max  function. The latter is commonly used in the output layer as it can compute
the  probability of multiclass labels. (b) Example of a feedforward multilayer neural
network (also referred to as multilayer perceptron) with two  classes, in which the
nodes in one layer are connected to all neurons in the next layer (fully connected
network). For each neuron j in the ﬁrst hidden layer, a nonlinear function is applied
to the weighted sum of the inputs. The result of this transformation (yj) serves as
input for the second hidden layer. The information is propagated through the net-
work up to the output layer, where the softmax function yields the probability of a
given observation belonging to each class.
the weights are set at random. When the training set is presented to
the network, this forward propagates the data through the nonlin-
ear transformation along the layers. The estimated output is then
compared to the true output, and the error is propagated from the
output towards the input, allowing the gradient descent algorithm
to adjust the weights as required. The process continues iteratively
until the error has reached its minimum value. The backpropaga-
tion algorithm does not work well with the original models of DNNs
that were based on sigmoid and hyperbolic tangent nonlinearities.
In these models, the information of the error becomes increasingly
smaller as it propagates backward from the output to the input
layer, to a point where initial layers do not get useful feedback on
how to adjust their weights − an issue known as the vanishing
gradient problem. Therefore, initially, the use of backpropagation
yielded poor solutions for networks with three or more hidden lay-
ers (Schmidhuber, 2015). In 2006, however, Hinton and colleagues
put forward the idea of “greedy layerwise training”, which consists
of two  steps: 1) an unsupervised step, where each layer is trained
individually and 2) a supervised step, where the previously trained
layers are stacked, one additional layer is added to perform the
classiﬁcation (the output layer), and the whole network parame-
ters are ﬁne-tuned (Hinton et al., 2006). This breakthrough led to
the fast-growing interest in deep learning and enabled the devel-
opment of at least two types of pre-trained networks that have
shown promising results: stacked autoencoders and deep belief
networks. It should be noted that these methods are not actual clas-
siﬁers themselves; instead, they are networks that are pre-trained
to learn useful patterns in the data and then fed to a real classiﬁer
at the ﬁnal layer. These two  types of networks and their unique
characteristics are described in Section 2.2 and 2.3.
2.1.3. Testing
The performance of a deep neural network can be evaluated
by several performance measures, such as sensitivity, speciﬁcity,
accuracy and F-score. Sensitivity refers to the proportion of true
positives correctly identiﬁed (e.g. the proportion of subjects that
were predicted as patient and are true patients), and speciﬁcity
refers to true negatives correctly identiﬁed (e.g. the proportion
of subjects that were predicted as healthy controls and are true
healthy controls). The accuracy of a classiﬁer represents the over-
all proportion of correct classiﬁcations. The statistical signiﬁcance
of this overall accuracy can be tested using parametric tests such
as permutation testing, which measures how likely the observed
accuracy would be obtained by chance. Metrics such as F-score and
balanced accuracy, which take into account each group’s sample
size, are particularly useful in cases where classes are unbalanced.
The F-score is a measure that combines precision or positive pre-
dictive value (proportion of individuals classiﬁed as cases were
actually cases) and sensitivity (proportion of true cases correctly
classiﬁed as such). Balanced accuracy, on the other hand, corre-
sponds to the average accuracy obtained on either class (Brodersen
et al., 2010).
2.1.4. Risk of overﬁtting and possible strategies
Due to the use of multiple nonlinear transformations, deep net-
works are highly complex models that involve the estimation of a
very large number of parameters. This can lead to the model learn-
ing particular ﬂuctuations in the training data that are irrelevant
Fig. 2. Effect of the depth of the model. Each dot corresponds to a neuroimage-based data visualized in a two-dimensional map. With more hidden layers, the data becomes
more  easily separable due to nonlinear transformations along the network (Plis et al., 2014).
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Fig. 3. (a) Shallow or simple autoencoder. In its shallow structure, an autoencoder is comprised of an input layer, that represents the original data (e.g., pixels in an image),
one  hidden layer that represents the transformed data, and an output layer that reconstructs the original input data. (b) Stacked autoencoder. Two simple autoencoders are
stacked  with a 2-class softmax classiﬁer as the ﬁnal layer. From each simple autoencoder, the output layer is discarded, and the hidden layer is used as the input layer for
next  autoencoder.
Fig. 4. Generic structure of a CNN. For illustrative purpose, this example only has one layer of each type; a real-world CNN, however, would have several convolutional and
pooling  layers (usually interpolated) and one fully-connected layer. (a) Input layer. In its simplest way, the data is inputted into the network in such a way  that each pixel
corresponds to one node in the input layer. (b) Convolutional layer. A 3 × 3 ﬁlter or kernel (in green) is used to multiply the spatially corresponding 3 × 3 nodes in the image.
The  resulting weighted sum is then passed through a nonlinear function to derive the output value of one node in the feature map. The repetition of this same operation
across all possible receptive ﬁelds results in one complete feature map. The same procedure with different kernels (in orange and blue) will result in separate complete
feature  maps. (c) Pooling layer. The size of each feature map  can be reduced by taking the maximum value (or average) from a receptive ﬁeld in the previous layer. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
for the purpose of classiﬁcation − an issue known as “overﬁtting”.
When this happens, the model will perform very well on the train-
ing data but will not be able to replicate its performance on unseen
data (Srivastava et al., 2014). The risk of overﬁtting is particu-
larly high in the context of neuroimaging, where the number of
data points (e.g. number of voxels) for a subject is much larger
than the total number of subjects, resulting in high-dimensional
data (Arbabshirani et al., 2016). However, there are a number of
strategies that can be used to minimise the risk of overﬁtting, col-
lectively known as “regularization”. A ﬁrst strategy involves the
use of weight decays (e.g., L1 and L2 norms) to penalise models
with very high weights. It has been observed that extreme (very
low or very high) weight values in a ML  model are symptomatic
of the model trying to learn the regularities of the data perfectly
(Moody et al., 1995). By forcing weights to remain low, the net-
work becomes less dependent on the training data and is able to
better generalise to unseen data (Nowlan and Hinton, 1992). A sec-
ond strategy, known as dropout, consists of temporarily removing
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a random number of nodes and their respective incoming and out-
going connections from the network during training. This means
that the contribution of dropped-out neurons to the activation of
downstream neurons is temporally removed on the forward pass
and that any weight updates are not applied to these neurons on
the backward pass. The aim of dropout is to extract different sets of
features that can independently produce a useful output, thereby
allowing higher levels of generalizability (Srivastava et al., 2014).
2.2. Autoencoders
Autoencoders are a special case of feedforward networks which
comprise of two main components. The ﬁrst component, i.e. the
“encoder”, learns to generate a latent representation of the input
data, whereas the second component, i.e. the “decoder”, learns to
use these learned latent representations to reconstruct the input
data as close as possible to the original (Fig. 3a) (Vincent et al.,
2010).
Since an autoencoder does not make use of labels, its train-
ing is an unsupervised learning process. In its shallow structure,
an autoencoder is comprised of three layers: an input layer, one
hidden layer and an output layer. The training to perform the
input-copying task can be useful to extract meaningful features
of the input data. This automatic feature extraction can be per-
formed using an error function (or loss function) that encourages
the model encoder to have speciﬁc characteristics, such as sparsity
of the representation (sparse autoencoders) and robustness to noise
(denoising autoencoders). Since autoencoders are automatic fea-
tures extractors, they can also be stacked to create a deep structure
to increase the level of abstraction of learned features. In this case,
the network is pre-trained, i.e. each layer is treated as a shallow
autoencoder, generating latent representations of the input data.
These latent representations are then used as input for the subse-
quent layers before the full network is ﬁne-tuned using standard
supervised learning (Fig. 3b) (Larochelle et al., 2007).
2.3. Deep belief networks
Deep belief networks (DBNs), proposed by Hinton et al. (2006),
are technically the ﬁrst DL models. Similar to stacked autoencoders,
DBNs are comprised of stacked shallow feature extractors, known
as restricted Boltzmann machines (RBMs). An RBM is composed by
only two layers: a visible layer and a hidden layer. Just like autoen-
coders, RBMs also aim to learn and extract useful features from
the data. However, RBMs differ from autoencoders with regards
to their training processes. RBMs can be interpreted as a stochastic
neural network. Therefore, instead of using deterministic functions
and the reconstruction error (like the autoencoders), the RBM uses
the maximum-likelihood estimation to ﬁnd a stochastic represen-
tation of the input in its hidden layer (latent features). To do this,
RBMs are usually trained using a gradient descent algorithm, with
the likelihood gradient being performed by an approximation algo-
rithm known as contrastive divergence (Hinton et al., 2006). Here
the input data, stored in the visible layer, are propagated to the
hidden layer as in a feedforward network, and the resulting sum
of the weighted inputs provides a measure of the neuron activa-
tion probability. The activation of hidden neurons can be thought
of as the network’s internal representation of the data, which is
then propagated back to the visible layer in an attempt to recon-
struct the input data from the network’s internal representation.
The network, therefore, learns by adjusting the weights based on
the discrepancy between the true and reconstructed data. Similarly
to autoencoders, RBMs can be stacked to create a deep network,
where the hidden layer representation of one RBM serves as input
layer for the following RBM, and the network can learn higher-level
features from lower-level ones to arrive at an abstract representa-
tion of the data. Furthermore, the neural network corresponding to
a trained DBN can be augmented by adding an output layer, where
units represent the labels corresponding to the input sample. This
results in a standard neural network for classiﬁcation that can be
further trained using supervised learning algorithms.
2.4. Convolutional neural networks
Convolutional neural networks (CNNs) are a special type of feed-
forward neural networks that were initially designed to process
images, and as such are biologically-inspired by the visual cortex
(LeCun et al., 1998). In addition to the input and output layers,
CNN can comprise of three types of layers: a convolutional layer, a
pooling layer, and a fully-connected layer (Fig. 4).
The convolutional layer is organized in several feature maps.
Every neuron in a feature map  is connected to a ﬁxed set of neurons
in a local region of the previous layer – the receptive ﬁeld – in such a
way that the whole image is covered (“local connectivity”). Within
the same feature map, the connections between each neuron and
the corresponding receptive ﬁeld share the same weights, whereas
different feature maps use different sets of weights (“weight shar-
ing”). As a result of this architecture, a feature map  can be thought
of as a “feature detector” that scans the whole image for the same
pattern. This pattern is usually known as the kernel. Kernels in a
CNN are learned during the training process, as opposed to in SVM,
where they are deﬁned a priori. In a network with several con-
volutional layers, each layer codes for increasingly more abstract
features (e.g. lines → edges → eyes → face). The pooling layer sim-
ply reduces the number of neurons of the previous convolutional
layer. The fully-connected layers are similar to the hidden lay-
ers from the conventional MLP  where the neurons are connected
to all neurons from the previous layer. All combined, the proper-
ties of CNN (local connectivity, weight sharing and pooling) result
in a signiﬁcant reduction in the number of parameters, which in
turn decreases the likelihood of overﬁtting, and alleviates compu-
tational processing.
3. Review of DL studies of psychiatric or neurological
disorders
In order to identify previous applications of DL in neuroimag-
ing studies of psychiatric or neurological disorders, a search was
conducted on 1st August 2016 across several databases (PubMed,
IEEE Xplore, Scopus and ArXiv) using the following search terms:
(“deep learning” OR “deep architecture” OR “artiﬁcial neural net-
work” OR “autoencoder” OR “convolutional neural network” OR
“deep belief network”) AND (neurology OR neurological OR psy-
chiatry OR psychiatric OR diagnosis OR prediction OR prognosis
OR outcome) AND (neuroimaging OR MRI  OR “Magnetic Resonance
Imaging” OR “fMRI” OR “functional Magnetic Resonance Imaging”
OR PET OR “Positron emission tomography”). This review did not
include EEG studies, although there is some evidence that DL can
also be used with this type of data, particularly in epilepsy (Page
et al., 2014). The initial search yielded a total of 172 articles. As the
next step, we  screened and cross-referenced these articles for stud-
ies that had applied a deep learning model to neuroimaging data
to investigate a psychiatric or neurologic condition; this identiﬁed
a total of 25 articles which were relevant to our review. We  orga-
nized these articles as follows: i) diagnostic studies,  which aimed
to classify patients from healthy controls, ii) studies on conversion
to illness,  which used baseline scans from individuals identiﬁed as
being at high risk of developing a psychiatric or neurologic disorder
to predict subsequent transition to the illness, and ﬁnally iii) stud-
ies predicting treatment response, which used baseline scans from
individuals with a neurological or psychiatric diagnosis to predict
64 S. Vieira et al. / Neuroscience and Biobehavioral Reviews 74 (2017) 58–75
Table 1
Diagnostic studies.
Authors, year Sample size Technique Features Previous
feature
selection
DL architecture Comparison Accuracy (%)
Gupta et al. (2013)a AD = 200 sMRI WB voxel-level No Sparse AE & CNN HC vs. AD 94.7
MCI  = 411 HC vs. MCI  86.4
HC  = 232 AD vs. MCI  88.1
HC vs. AD vs. MCI  85.0
Payan and Montana
(2015)a
HC = 755 sMRI WB voxel-level No Sparse AE & CNN HC vs. AD 95.4
AD  = 755 HC vs. MCI 92.1
MCI = 755 AD vs. MCI  86.8
HC vs. AD vs. MCI  89.5
Hosseini-Asl et al.
(2016) a,b
HC = 70* sMRI WB voxel-level No AE & CNN HC vs. AD 97.6
AD  = 70* HC vs. MCI  90.8
MCI  = 70* AD vs. MCI  95.0
HC vs. AD vs. MCI  89.1
Chen et al. (2015)a HC = 123 sMRI WB voxel-level Yes SAE HC vs. AD 89.0
AD  = 94 HC vs. MCI 81.7
MCI = 121
Liu et al. (2015a)a HC = 204 sMRI WB region-level Yes SAE HC vs. AD 82.6
AD  = 180 HC vs. MCI  72.0
MCI  = 374
Gao and Hui (2016) HC = 117 CT WB voxel-level No CNN HC vs. AD vs. Lesion 87.7
AD  = 51
Lesions = 118
Sarraf and Toﬁghi
(2016)a
HC = 15 rsfMRI WB voxel-level No CNN HC vs. AD 96.9
AD  = 28
Suk et al. (2016)a HC = 31 rsfMRI WB region-level Yes DAE HC vs. MCI  72.6
MCI  = 31
HC = 25 rsfMRI WB region-level Yes DAE HC vs. MCI  81.1
MCI  = 12
Hu et al. (2016)a HC = 52 rsfMRI WB region-level No SAE HC vs. MCI  87.5
MCI  = 48
Han et al. (2015)a HC = nr rsfMRI WB voxel-level No AE & CNN HC vs. AD 80.0
AD  = nr
Liu et al. (2015a)a HC = 77 sMRI & PET WB region-level Yes SAE HC vs. AD 91.4
AD  = 85 HC vs. MCI  82.1
MCI  = 169
Suk et al. (2014)a HC = 101 sMRI & PET WB region-level Yes DBM HC vs. AD 94.9
AD  = 93 HC vs. MCI  80.6
MCI  = 204
Liu et al. (2014)a HC = 77 sMRI & PET WB region-level Yes SAE HC vs. AD 87.8
AD  = 65 HC vs. MCI 76.9
MCI = 169
Suk et al. (2015b)a HC = 52 sMRI & PET & CSF WB region-level Yes DW-S2 MTL  HC vs. AD 95.1
AD  = 51 HC vs. MCI  80.1
MCI  = 99 HC vs. AD vs. MCI  62.9
HC  = 229 sMRI & PET & CSF WB region-level Yes DW-S2 MTL  HC vs. AD 90.3
AD  = 198 HC vs. MCI  70.9
MCI  = 403 HC vs. AD vs. MCI  57.7
Liu et al. (2015b)a HC = 77 sMRI & PET & MMSE  WB region-level Yes SAE HC vs. AD 90.1
AD  = 85 HC vs. AD vs. MCI  59.2
MCI  = 169
Suk et al. (2015a)a HC = 52 sMRI & PET & CSF &
MMSE  & ADASCog
WB  region-level Yes SAE HC vs. AD 98.8
AD  = 51 HC vs. MCI  90.7
MCI  = 99 AD vs. MCI  83.7
Li et al. (2014)a HC = 52 sMRI & PET & CSF &
MMSE  & ADASCog
WB  region-level Yes MLP  HC vs. AD 91.4
AD  = 51 HC vs. MCI  77.4
MCI  = 99
Suk and Shen (2013)a HC = 52 sMRI & PET & CSF &
MMSE  & ADASCog
WB  region-level No SAE HC vs. AD 95.9
AD  = 51 HC vs. MCI  85.0
MCI  = 99
Han et al. (2015)c HC = nr rsfMRI WB voxel-level No AE & CNN HC vs. ADHD 65.0
ADHD = nr
Deshpande et al.
(2015)c
HC = 744 rsfMRI WB region-level Yes FCC HC vs. ADHD-C ∼90.0
ADHD-C = 260 HC vs. ADHD-I ∼90.0
ADHD-I = 173 ADHD-C vs. ADHD-I 95.0
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Table  1 (Continued)
Authors, year Sample size Technique Features Previous
feature
selection
DL architecture Comparison Accuracy (%)
Kuang et al. (2014)c HC = 69 to 110 rsfMRI ROI (PFC)
ROI (VC)
ROI (CC)
Yes DBN HC vs. ADHD-C vs.
ADHD-I vs. ADHD-H
37.4 to 71.8***
ADHD-C = 16 to
95
HC vs. ADHD-C vs.
ADHD-I vs. ADHD-H
34.4 to 68.8***
ADHD-I = 2 to 5 HC vs. ADHD-C vs.
ADHD-I vs. ADHD-H
37.1 to 72.7***
ADHD-H = 1 to
50
Kuang and He (2014)c HC = 42 to 95 rsfMRI ROI (PFC) Yes DBN HC vs. ADHD-C vs.
ADHD-I vs. ADHD-H
44.4 to 80.9***
ADHD-C = 0 to
77
ADHD-I = 0 to
44
ADHD-H = 0 to
6
Hao et al. (2015)c HC = 69 to 110 rsfMRI ROI (PFC, VC, SSC and
CC combined)
Yes DBaN HC vs. ADHD-C vs.
ADHD-I vs. ADHD-H
48.9 to 72.7***
ADHD-C = 16 to
95
ADHD-I = 2 to 5
ADHD-H = 1 to
50
Plis et al. (2014) HC = 191 sMRI WB  voxel-level No DBN HC vs. SZ 91**
SZ and
FEP = 198
Kim et al. (2016)d HC = 50 rsfMRI WB  region-level Yes SAE HC vs. SZ 85.8
SZ  = 50
Munsell et al. (2015) HC = 48 DTI WB  region-level No SAE HC vs. TLE 69.0
TLE  = 70
Yang et al. (2014) HC = 31 sMRI ROI (Cerebellum) No SAE HC vs. SCA2 vs. SCA6
vs. AT
86.3
SCA2 = 4
SCA6 = 27
AT = 18
a ADNI dataset.
b CADDementia dataset.
c ADHD-200 dataset.
d COBRE dataset.
* Sample sizes for the ﬁne-tuning stage only (pre-training included an additional 386 samples).
** F-score.
*** Range of accuracies obtain from the different datasets used; HC, healthy controls; SZ, schizophrenia, FEP, ﬁrst episode psychosis; ADHD, attention deﬁcit/hyperactive
disorder; ADHD-C, attention-deﬁcit/hyperactive disorder combine subtype; ADHD-I, attention-deﬁcit/hyperactive disorder inattentive subtype; ADHD-H, attention-
deﬁcit/hyperactive disorder hyperactive subtype; SCA2, spinocerebellar ataxia type 2; SCA6, spinocerebellar ataxia type 6; AT, ataxia-telangiectasia; TLE, temporal lobe
epilepsy; AD, Alzheimer’s disease; MCI, mild cognitive impairment; CC, cingulate cortex; VC, visual cortex, PFC, pre-frontal cortex; SSC, somatosensory cortex; sMRI, struc-
tural  MRI; rsfMRI, resting-state functional MRI; CT, computed tomography; PET, Positron emission tomography; DTI, diffusion tensor imaging; CSF, cerebrospinal ﬂuid; MMSE,
mini  mental state examination; ADASCog, Alzheimer’s Disease Assessment Scale’s cognitive subscale; AE, autoencoder, SAE, stacked autoencoder; FCC, fully-connected cas-
cade;  DBN, deep belief network, DBaN, deep Bayesian network; CNN, convolutional neural network; DAE, deep autoencoder; DBM, deep Boltzman machine; DW-S2 MTL,
deep  weighted subclass-based sparse multi-task learning; MLP, multilayer perceptron; nr, not reported.
subsequent treatment response. These studies are summarised in
Tables 1, 2 and 3 which provide the following information: sample
size; type of data used as input; whether a whole brain (WB) or
region of interest (ROI) approach was used; whether the informa-
tion inputted into the model comprised of voxel or region-level
features; whether feature selection was or was  not used before
inputting the data into the model; general type of DL architecture;
diagnostic groups being investigated; and accuracy. Whenever
performed, we also report the accuracies obtained for multiclass
classiﬁcations, which involve discriminating between more than
two classes (e.g. healthy controls vs. mild cognitive impairment vs.
Alzheimer’s disease).
3.1. Diagnostic studies
Studies using DL to classify psychiatric or neurological patients
from healthy individuals have used a range of neuroimaging modal-
ities including structural MRI  (sMRI), resting-state fMRI (rsfMRI),
positron emission tomography (PET) and a combination of differ-
ent modalities (multimodal studies) (see Table 1). From Table 1 it
can be seen that the vast majority of these studies were carried out
in Alzheimer’s disease (AD) and its prodromal stage, mild cognitive
impairment (MCI). In addition, a smaller number of studies exam-
ined psychosis, attention deﬁcit/hyperactivity disorder (ADHD),
cerebellar ataxia and temporal lobe epilepsy (TLE). Within each
diagnostic category, we ﬁrst give an overview of the studies that
have used a single neuroimaging modality, followed by studies that
employed a multimodal approach and, ﬁnally, studies that have
combined neuroimaging and clinical data within a single classiﬁer.
3.1.1. Mild Cognitive Impairment and Alzheimer Dementia
In one of the ﬁrst studies using DL in AD and MCI, Gupta et al.
(2013) argued that, since (i) natural images and brain imaging have
similar, and therefore interchangeable, low-level features (e.g. lines
and corners) and (ii) natural images, contrary to neuroimaging, are
abundant, then natural images could be used to learn low level
features which could then be used to identify lesions along the sur-
face and ventricles of the brain. This process, whereby the features
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Table 2
Conversion to illness.
Authors, year Sample size Technique WB voxel-level/WB
region-level/ROI
Previous feature
selection
DL architecture Comparison Accuracy
(%)
Liu et al. (2015a)a HC = 204 sMRI WB region-level Yes SAE AD vs MCI-C vs
MCI-NC vs HC
46.3
AD  = 180
MCI-C = 160
MCI-NC = 214
Suk et al. (2014)a MCI-C = 76 sMRI & PET WB region-level Yes DBM MCI-NC vs
MCI-C
71.6
MCI-NC = 128
Liu et al. (2015a)a HC = 77 sMRI & PET WB region-level Yes SAE AD vs MCI-C vs
MCI-NC vs HC
53.8
AD  = 85
MCI-C = 67
MCI-NC = 102
Liu et al. (2014)a HC = 77 sMRI & PET WB region-level Yes SAE AD vs MCI-C vs
MCI-NC vs HC
47.4
AD  = 65
MCI-C = 67
MCI-NC = 102
Suk et al. (2015b)a MCI-C = 43 sMRI & PET & CSF WB region-level Yes DW-S2 MTL  MCI-NC vs
MCI-C
74.2
MCI-NC = 56 AD vs MCI-C vs
MCI-NC vs HC
53.7
AD  = 51
HC = 52
MCI-C = 167 sMRI & PET & CSF WB region-level Yes DW-S2 MTL  MCI-NC vs
MCI-C
73.9
MCI-NC = 236 AD vs MCI-C vs
MCI-NC vs HC
47.8
HC  = 52
AD = 198
Li et al. (2014)a MCI-C = 43 sMRI & PET & CSF &
MMSE  & ADASCog
WB  region-level Yes MLP  MCI-NC vs
MCI-C
57.4
MCI-NC = 56
Suk and Shen (2013)a MCI-C = 43 sMRI & PET & CSF &
MMSE  & ADASCog
WB  region-level No SAE MCI-NC vs
MCI-C
75.8
MCI-NC = 56
Suk et al. (2015a)a MCI-C = 43 sMRI & PET & CSF &
MMSE  & ADASCog
WB  region-level Yes SAE MCI-NC vs
MCI-C
83.3
MCI-NC = 56
a ADNI dataset; HC, healthy controls; AD, Alzheimer’s disease; MCI-NC, mild cognitive impairment non-converters; MCI-C, mild cognitive impairment converters; sMRI,
structural MRI; PET, Positron Emission Tomography; CSF, cerebrospinal ﬂuid; MMSE, mini mental state examination; ADASCog, Alzheimer’s Disease Assessment Scale’s
cognitive subscale; SAE, stacked autoencoder; DBM, deep Boltzmann machine; DW-S2 MTL, deep weighted subclass-based sparse multi-task learning; MLP, multilayer
perceptron.
Table 3
Treatment outcome.
Authors, year Sample size Technique WB  voxel-level/WB
region-level/ROI
Previous feature
selection
DL architecture Comparison Accuracy (%)
Munsell et al. (2015) TLEns = 41 DTI WB region-level No SAE TLEns vs TLEs 57.0
TLEs  = 29
HC, healthy controls; TLE-ns, temporal lobe epilepsy without seizures; TLE-ns, temporal lobe epilepsy with seizures; DTI, diffusion tensor imaging.
learned in one set of data are used to solve a problem in another
set of data, is known as “transfer learning”. Based on this premise,
the authors pre-trained a sparse autoencoder to learn features from
natural images, which were then applied to structural MRI  data via
a CNN, achieving a classiﬁcation accuracy of 94.7% for AD versus
controls, 86.4% for MCI  versus controls and 88.1% for AD versus
MCI. Consistent with the authors’ hypothesis, this method outper-
formed the one where the learned features were extracted from the
neuroimaging data (93.8%, 83.3% and 86.3% for the same compar-
isons, respectively). However, a few years later and using a similar
approach, Payan and Montana (2015) found comparable classiﬁca-
tion accuracies using features that were learned from the structural
MRI  data itself. This could potentially be explained by the fact that
Payan and Montana (2015) used a much larger sample, as well as by
the fact that authors used 3D brain images, as opposed to 2D, which
possibly contain more useful patterns for classiﬁcation. Indeed,
Payan and Montana (2015) reported that, in general, the models
based on 3D outperformed those based on 2D brain images (AD vs.
HC (2D/3D) = 95.4%/95.4%; AD vs. MCI  (2D/3D) = 82.2%/86.8%; MCI
vs. HC (2D/3D) = 90.1%/92.1%). The best accuracy (97.6%) from sin-
gle modality studies came from Hosseini-Asl et al. (2016), who also
used transfer learning. Instead of extracting features from natural
images and then ﬁne-tuning the model on Alzheimer’s patients and
controls, as seen in Gupta et al. (2013); Hosseini-Asl et al. (2016)
used one Alzheimer’s dataset for pre-training and another inde-
pendent Alzheimer’s dataset to ﬁne-tune the model. By performing
the pre-training on an Alzheimer’s dataset, this approach allowed
for the network to extract generic features related to AD biomark-
ers, such as the ventricular size, hippocampus shape, and cortical
thickness as opposed to more generic low-level features as in Gupta
et al. (2013). By using two independent samples during the com-
plete learning process, the ﬁnal learned features for classiﬁcation
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are much less dataset-speciﬁc, and should therefore be more gen-
eralizable. The ﬁnal model’s architecture was also deeper than in
previous studies, which probably also contributed to the high accu-
racy. Taken collectively, these studies suggest that the application
of DL to structural MRI  data allows the classiﬁcation of individu-
als with AD and MCI  with high levels of accuracy. Consistent with
the increasing popularity of CNN models, studies that have applied
either CNN or a combination of AE and CNN have shown better
performances compared to those using only AE, although it should
be noted that the former group of studies tended to have larger
samples than the latter group. In addition, and similar to the trend
reported in computer vision competitions and research, the best
performances were obtained by the deepest CNN models.
Studies of AD and MCI  using resting-state imaging have also
achieved promising results. For example, Han et al. (2015) designed
a hierarchical convolutional sparse autoencoder (HCSAE), which
essentially extracts the most discriminating features from the
resting-state data and encodes them in a convolutional manner.
This particular arrangement allows for the extraction of the most
useful information while conserving abundant detail. The ﬁnal
model classiﬁed AD and controls with an 80.0% accuracy and sig-
niﬁcantly outperformed SVM, which only yielded an accuracy of
50% (Fig. 4). While this is a promising result, the model assumed
that functional networks were statistic over time − an assumption
which underlies the vast majority of ML  applications to resting-
state neuroimaging data. However, recent studies have shown that
the network-level functional organization of the brain is dynamic
rather than static (Hutchison et al., 2013). Suk et al. (2016) have
addressed this issue by developing an approach which classiﬁes
people with MCI  and healthy controls using a deep autoencoder to
extract hierarchical nonlinear relations among brain regions, whilst
modelling the inherent functional dynamics of resting-state data.
This was also one of the few studies in which the same DL model
was tested against and surpassed other competing models in two
independent datasets (72.6% for dataset 1 and 80.0% for dataset 2),
thus providing evidence of replicability, a crucial feature for diag-
nostic tools. In line with the studies using structural imaging, the
best performance for the classiﬁcation of AD patients with resting-
state data was  also obtained by a CNN model with an accuracy of
96.9% (Sarraf and Toﬁghi, 2016). These studies provide initial evi-
dence that brain activity at resting state can be useful in identifying
MCI  and AD patients. We  note that, compared to the performances
obtained from structural data, DL models applied to functional data
seem to perform worse. This discrepancy could be explained by the
substantial difference in sample size between the two  types of stud-
ies − while the smallest study using structural data included 140
subjects (Hosseini-Asl et al., 2016) the largest study using functional
data included 62 subjects (Suk et al., 2016).
With regards to multimodal studies, Liu et al. (2014) applied
a stacked autoencoder (SAE) to structural and PET data and suc-
cessfully distinguished AD and MCI  from controls with an accuracy
of 87.8% and 76.9%, respectively. Using a very similar dataset, the
same team (Liu et al., 2015a) achieved a better performance by
designing a model where the hidden layers were able to infer the
correlations between sMRI and PET, thus better capturing the syn-
ergy between the two modalities. This model classiﬁed AD and MCI
against controls with an accuracy of 91.4% and 82.1%, respectively.
Interestingly, the application of the same model to a structural data
alone resulted in less impressive accuracies of 82.6% and 72% for AD
and MCI, respectively. This discrepancy suggests that the integra-
tion of structural and functional data may  improve classiﬁcation
accuracy. However, this conclusion should be drawn with great
caution since that the authors did not report classiﬁcation accuracy
for PET data alone.
Finally, four studies have tried combining neuroimaging data
with clinical information to build a more robust classiﬁcation
model. For example, Suk and Shen (2013) used a SAE to extract
latent features from neuroimaging data (sMRI, PET and CSF), which
were then used to predict clinical data (measured using the Mini-
Mental State Examination – MMSE  – and Alzheimer’s Disease
Assessment Scale’s cognitive subscale – ADAS-cog) and class labels.
As the ﬁnal step, the resulting learned features were used to classify
AD and MCI  from healthy individuals with an accuracy of 95.9% and
85.0%, respectively. Notably, two more studies (Li et al., 2014; Suk
et al., 2015a) that have used the same exact sample (taken from the
publicly available dataset ADNI; Alzheimer’s Disease Neuroimag-
ing Initiative) and the same types of data (sMRI, PET, CSF, MMSE
and ADAS-cog) have also reported high accuracies for both AD
and MCI  despite using different implementations of DL.  In general,
studies combining clinical with neuroimaging data have, in gen-
eral, reported higher accuracies than studies using single modality
or multiple neuroimaging modalities. This is in line with previous
studies using conventional ML  methods (e.g. Willette et al., 2014;
Moradi et al., 2015; Zhang and Shen, 2012) and highlights the use-
fulness of adding clinical information in the classiﬁcation of AD and
its prodromal phase.
3.1.2. Attention-deﬁcit/hyperactive disorder
With regards to attention-deﬁcit/hyperactivity disorder
(ADHD), all ﬁve studies included here have used resting-state
neuroimaging data. For example, Deshpande et al. (2015) applied
a fully connected cascade artiﬁcial neural network – a variation
of the multilayer perceptron – to functional connectivity from
ADHD and healthy controls. The model successfully distinguished
between the inattentive and combined subtypes from healthy
controls with an accuracy of 90% for both comparisons, while
the two subtypes were discriminated with an accuracy of 95%.
Connections between frontal areas and the cerebellum were
identiﬁed as the most discriminating features. There is also evi-
dence that healthy children and children diagnosed with three
different ADHD subtypes (inattentive, hyperactive and combined)
can be distinguished in one single model using a multiclass
approach, without the need to perform binary classiﬁcations
between healthy controls and each ADHD subtypes. This evidence
comes from three studies that have used data from different sites
taken from the ADHD-200 consortium, a data-sharing platform
aimed at understanding the neural basis of ADHD (Milham et al.,
2012). Kuang et al. (2014) attempted to discriminate between
healthy controls and ADHD subtypes (inattentive, hyperactive and
combined) using data acquired from three different sites. Rather
than looking at the whole brain, the authors ﬁrst parcellated the
brain and trained different DBNs for each brain area to examine
which part of the brain best discriminated ADHD (regardless of
subtypes) from healthy controls. A 4-way DBN was  then performed
for the each best discriminating area – prefrontal (PFC), cingulate
(CC) and visual (VC) cortex – in each one of the three datasets
separately (dataset 1: PFC = 37.4%, CC = 37.1%, VC = 34.4%; dataset
2: PFC = 54.0%, CC = 54.0%, VC = 51.2%; dataset 3: PFC = 71.8%,
CC = 72.7%, VC = 68.8%). Kuang and He (2014) partially replicated
these ﬁndings by applying the same DL approach to functional
measures of the prefrontal cortex; this allowed a 4-way classiﬁ-
cation accuracy of 44.4%, 55.6% and 80.9% in three independent
samples from the ADHD-200 consortium. Finally, Hao et al. (2015)
identiﬁed the most discriminating areas – prefrontal, cingulate,
somatosensory and visual cortex – and then combined them
within a single model. The resulting input data were put through a
deep Bayesian network (DBaN), where a DBN was used to reduce
the dimensionality of the data and a Bayesian network was  used
to extract the relationships between the data. The resulting model
achieved a 4-way classiﬁcation accuracy of 48.8%, 54.0% and 72.7%
for three independent samples also taken from the ADHD-200
consortium. These three studies suggest that DL  can be used to
68 S. Vieira et al. / Neuroscience and Biobehavioral Reviews 74 (2017) 58–75
solve multiclass classiﬁcations problems, as all performances were
well above chance level (25% for a classiﬁcation with 4 classes).
In addition, these studies suggest that DL can extract meaningful
information from patterns of brain functioning to classify ADHD
from controls and, more notably, to differentiate between ADHD
subtypes. Nevertheless, we note that all four studies conducted in
ADHD had unbalanced sample sizes between classes. For example,
in Kuang et al. (2014), there were just between 2 and 5 children
in the Inattentive subtype within each site, while the number of
healthy children ranged from 69 to 110 per site. Similarly, each
site in Kuang and He (2014) did not include any participants on at
least one ADHD subtype which may  have introduced a bias in the
4-way classiﬁcation performed across all sites. With the exception
of Hao et al. (2015) which reported sensitivity and speciﬁcity, all
studies assessed model performance by estimating the overall
accuracy. This metric is simply the proportion of participants
correctly identiﬁed, and therefore does not take the unbalance
between classes into account; this means that it is possible to
have a good overall accuracy even if several participants from a
class are misclassiﬁed (or even if all participants from a class are
misclassiﬁed if the sample size for that class is very small compared
to the total sample size). Therefore, given the highly imbalanced
sample sizes, the possibility that the performances reported in
these studies are inﬂated cannot be ruled out. This possibility is
supported by the observation of much lower sensitivities (43.9%,
22.9% and 55.6% for each site) than speciﬁcities (68.8%, 87.7% and
83.0%), in Hao et al. (2015).
3.1.3. Psychosis
With respect to psychosis, two studies have been performed
with promising results. Using structural MRI  data from four
independent studies, Plis et al. (2014) applied a DBN to the
original pre-processed images obtaining an impressive F-score
of 91%. While this was a highly promising result, the patients
group included both ﬁrst episode and chronic schizophrenia
patients, which could have diluted the models’ performance. More
recently, Kim et al. (2016) extracted functional connectivity pat-
terns obtained from resting-state functional MRI  of individuals
diagnosed with schizophrenia and healthy controls and performed
a series of experiments with an SAE-based model, in which differ-
ent hyperparameters were tested. The proposed model consisted of
an SAE with weight sparsity control, i.e. only a random selection of
neurons in a given layer was activated, that classiﬁed schizophre-
nia patients and controls with an accuracy of 85.5%, outperforming
SVM by a margin of 8.1%. Consistent with the literature on brain
functional abnormalities in schizophrenia (Kühn and Jürgen, 2013;
van der Meer et al., 2010), the most relevant features for the clas-
siﬁcation were the functional connectivity between the thalamus
and the cerebellum, the frontal and temporal areas and between the
precuneus/posterior cingulate cortex and the striatum. Despite this
encouraging result, the sample sizes for each class were modest (50
for each group) and, therefore, it is not clear how well these ﬁnd-
ings will generalise to a different sample. Nevertheless, both studies
suggest that DL can effectively classify psychosis patients on the
basis of neuroanatomical and neurofunctional information. Despite
the evidence that structural and functional data provide comple-
mentary information on the neural basis of psychosis (Cabral et al.,
2016; Radua et al., 2012; Schultz et al., 2012), to date there have
been no DL studies using a multimodal approach in psychosis. In
addition, despite the evidence that psychosis, similar to AD, is pre-
ceded by a prodromal stage (Yung et al., 2005), there have been
no studies applying DL to neuroimaging data to classify individu-
als at high risk of developing psychosis from healthy controls or
distinguishing between high risk individuals who will and will not
develop the illness.
3.1.4. Temporal lobe epilepsy
One study examined the potential of DL to classify healthy indi-
viduals and patients diagnosed with temporal lobe epilepsy (TLE)
from diffusion-weighted images (DWI) (Munsell et al., 2015). A
stacked autoencoder was  used to extract meaningful features from
patients’ connectome while SVM was  chosen as the classiﬁer. Deep
learning was  suggested as an attractive ML  alternative because
it is capable of encoding latent, nonlinear relationships in high
dimension data. This combination yielded a relatively modest accu-
racy of 69%. In addition, this model was  outperformed by another
approach where features were extracted using a well-known linear
automated method (ElasticNet) instead, which achieved an accu-
racy of 80%. This discrepancy in favour of the second model could
potentially be explained by the absence of any form of regulariz-
ers in the ﬁrst model. Given the high complexity resulting from the
numerous parameters to be estimated, DL models are more prone
to overﬁtting (high performance on the training data while per-
forming poorly on unseen data) than conventional ML  approaches.
One standard solution, that the authors did not use, is to address
this issue is by tuning the level of model complexity and penalizing
highly intricate ones in order to have better generalizing models.
3.1.5. Cerebellar ataxia
One study was conducted in cerebellar ataxia (CA), a neu-
rodegenerative disorder that affects mainly the cerebellum, with
multiple genetics variations each with its characteristic pattern of
anatomical degeneration. Yang et al. (2014) applied a stacked AE to
T1-weighted images of the cerebellum taken from healthy controls
and individuals suffering from three CA subtypes: spinocerebellar
ataxia type 2 (SCA2), spinocerebellar ataxia type 6 (SCA6) or ataxia-
telangiectasia (AT). The proposed method classiﬁed the four groups
with an accuracy of 86.3%, an impressive result for a 4-way classi-
ﬁcation. However, the confusion matrix reported by the authors
indicates that no case with the SCA2 subtype was correctly classi-
ﬁed. Because the sample size of this group (only four participants)
contributed very little for the total sample size (80), it is still pos-
sible to misclassify all its cases and achieve a low error rate. In
such cases, a high accuracy can be misleading, as it may  reﬂect an
overestimation of the algorithm’s performance (Arbabshirani et al.,
2016). Balanced accuracy, for example, is a potentially useful alter-
native as it calculates the average of correct predictions of each
class individually (Alberg et al., 2004).
In short, since the ﬁrst study published in 2013, there is already
preliminary evidence that DL allows the accurate classiﬁcation of
a range of neurologic and psychiatric disorders, by extracting dis-
criminating features from either single or multimodal imaging as
well as other types of data such as clinical and cognitive informa-
tion.
3.2. Conversion to illness
3.2.1. From Mild Cognitive Impairment to Alzheimer Dementia
A total of 8 studies have attempted to predict transition to ill-
ness using neuroimaging data, and all of them have focussed on
the transition from MCI  to AD (Table 2). With one exception (Liu
et al., 2015a), all studies used a multimodality approach, with three
of them also including clinical measures in the prognostic model.
The highest accuracy (83.3%), was  achieved by a model which
included sMRI, PET, CSF and two clinical measures: the MMSE  and
the ADAS-cog (Suk et al., 2015a). Interestingly, the lowest perfor-
mance (57.4%) resulted from a model which used the same input
data (sMRI, PET, CSF, MMSE  and ADASCog) and a similar sample
size (Li et al., 2014). However, the two studies differed on the DL
approach, with the former employing a semi-supervised approach
with a multilayer perceptron pretrained using a stacked sparse
autoencoder, and the latter using a pure supervised approach.
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These ﬁndings highlight the potential impact of the DL architecture
on performance, although we cannot exclude the contribution of
other sample-speciﬁc factors to the results (e.g. recruitment crite-
ria). Overall, this initial sample of studies suggests that individuals
diagnosed with MCI  who later convert to dementia can be identiﬁed
using cutting-edge DL methods. Although, in general, accuracies are
not as high as when classifying AD or MCI  from healthy controls,
this is not surprising since brain differences as well as clinical and
cognitive symptoms between those identiﬁed as being at risk who
do and do not develop a disorder are likely to be subtle. In addition
to these encouraging results, the suitability of DL to multiclass clas-
siﬁcation means this analytical approach can easily be employed
to examine the biomarkers of different stages of the illness. Four
studies have taken advantage of this by conducting 4-way classi-
ﬁcations to discriminate between no eminent risk of AD (healthy
controls), individuals in the prodromal stage who did not (MCI-
C) and did develop dementia (MCI-C) and established Alzheimer’s
(AD). Accuracies ranged from 46.3% to 53.8%. By using a deep Boltz-
mann machine to extract features from structural MRI  and PET
images, Liu et al. (2015a) classiﬁed the four groups with an over-
all accuracy of 53.8%. Suk et al. (2015b) examined the replicability
of a DL approach known as deep weighted subclass-based sparse
multi-task learning (DW-S2 MTL) in two different datasets, con-
sidering both binary and multi-way comparisons. The proposed
model, speciﬁcally designed to mitigate the effect of less useful fea-
tures for classiﬁcation, showed a comparable performance for both
binary (74.2% vs. 73.9%) and 4-way (53.7% vs. 47.8%) classiﬁcations,
thus suggesting good replicability. Taken collectively, these studies
provide initial evidence that DL methods could be used to discrim-
inate amongst different stages of illness − a common challenge in
standard clinical settings.
3.3. Treatment outcome
Prediction of response to treatment is a research area of high
clinical interest. In several psychiatric and neurological disorders,
a better understanding of why some patients beneﬁt from a cer-
tain treatment whereas others do not, could help clinicians make
more-effective treatment decisions and improve long-term clinical
outcomes (Mechelli et al., 2015). However, so far, only one study
has used DL to predict clinical response to treatment (Table 3).
Munsell et al. (2015) attempted to develop an algorithm that dis-
tinguished between patients with TLE who did and did not beneﬁt
from surgical treatment. This was implemented using a stacked
autoencoder to extract meaningful features from the connectome
of patients who were then classiﬁed using SVM. This model, how-
ever, yielded a low accuracy of 57%. For comparison, the author
investigated another option where features were extracted with an
alternative linear approach instead of an autoencoder. This second
model resulted in a higher accuracy of 70%. Again, this discrepancy
in favour of the second model could potentially be explained by the
absence of any form of regularizers in the ﬁrst model. This model
comprised 4 layers, resulting in a high number of weights to be
estimated which, together with a modest sample size (41 patients
without seizures and 29 with seizures after treatment), might have
resulted in overﬁting.
3.4. How does DL compare to a traditional machine learning
approach?
A total of twenty-ﬁve studies included in this review com-
pared a DL model against a kernel-based model (SVM or MKL) in
order to elucidate how DL compares to a more conventional ML
approach. The results of these comparisons are shown in Fig. 5. It
can be seen that, for the majority of studies, DL showed improved
performance compared to SVM. Given the small sample of stud-
ies, it is difﬁcult to identify speciﬁc characteristics of the studies
associated with greater or smaller improvement in performance
following the implementation of DL. However, a margin favour-
ing DL studies appears to be more evident in studies that have
integrated different modalities with cognitive and/or clinical data
(Fig. 6). This anecdotal observation is consistent with the notion
that DL is a powerful tool for detecting abstract relations within
the data, especially between different types of data that are likely
to be associated in complex ways, such as neuroimaging and clini-
cal/cognitive information (Plis et al., 2014).
Since DL requires a large number of observations to learn
increasingly complex patterns compared to conventional ML  meth-
ods, one would expect to ﬁnd a greater difference between the two
methods as sample size increases. However, the effect of sample
size on the difference in performance is unclear, possibly due to
the small number of studies currently available. There is a minor-
ity of studies where SVM/MKL matched or even outperformed the
proposed DL model. Amongst these, Munsell et al. (2015) reported
the largest margin favouring SVM. However, this article had one of
the smallest sample sizes (118 for the diagnostic comparison and 70
for the treatment outcome comparison) while employing one of the
deepest networks with 5 layers. Notably, out of all the studies com-
paring the two approaches, Munsell et al. (2015) was the only one
that did not make any formal attempt to prevent overﬁtting of the
DL model, for example through the use of regularization. We  note
that susceptibility to overﬁtting becomes more pronounced when
deeper and thus more complex networks are used, as in the study
by Munsell et al. (2015), due to the higher number of weights to be
estimated (Srivastava et al., 2014). Therefore, we  speculate that the
use of small sample sizes, coupled with the high-dimensionality
of the data (i.e. when the number of variables highly exceeds the
number of participants), may  have increased the risk of overﬁtting
in this study.
4. Discussion
ML  has been gaining considerable attention in the neuroimaging
community due to its advantages over traditional analytical meth-
ods based on mass-univariate statistics. In particular, ML  methods
take the inter-correlation between regions into account, while
mass-univariate methods operate under the assumption that dif-
ferent regions act independently. In addition, ML  methods can be
used to make inferences at the single-subject level − a critical
difference with mass-univariate analytical methods that are only
sensitive to differences at group-level. DL is a type of ML  which is
increasingly used in neuroimaging after leading to major scientiﬁc
advances in the areas of speech recognition, computer vision and
natural language processing by signiﬁcantly outperforming other
state-of-the-art classiﬁcation methods (Krizhevsky et al., 2012; Le
et al., 2012). There are two  main characteristics that distinguish DL
from conventional ML  methods: ﬁrst, DL is capable of learning fea-
tures from the raw data without the requirement for a priori feature
selection, resulting in a more objective or less bias-prone process;
second, DL uses a hierarchy of nonlinear transformations, which
make this approach ideally suited for detecting complex, scattered
and subtle patterns in the data. Given its ability to detect abstract
patterns from the data, DL can be considered a promising tool in
neuroimaging, as most brain-based disorders are characterised by
a scattered and diffused pattern of neuroanatomical and neuro-
functional alterations (Plis et al., 2014). In previous sections of this
review, we have described the most common DL architectures and
have provided an overview of the studies that have applied DL to
neuroimaging data to investigate psychiatric and neurological dis-
orders. In this ﬁnal section, we  discuss the main themes that have
emerged from the review of these studies. These will include (i)
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consistencies and inconsistencies in the existing literature (ii) the
promise of CNNs, (iii) the issue of multiclass classiﬁcation, (iv) how
DL performs compared with conventional ML  methods, (v) inter-
pretability of DL in neuroimaging, (vi) the challenge of overﬁtting
and (vii) technical expertise and computational requirements. We
conclude by discussing possible directions for future research.
4.1. Main conclusions from the existing literature
The majority of published studies have been conducted in
patients with MCI  and/or AD; this may  be explained by the
availability of ADNI, a very large open-source dataset including
thousands of patients, to the neuroimaging community (Mueller
et al., 2005a, 2005b). However, studies have also been conducted
in other disorders including ADHD, psychosis, TLE and cerebellar
ataxia. Taken collectively, the ﬁndings published so far suggest
that DL can be applied to neuroimaging data, including both struc-
tural and functional modalities, to classify diagnostic groups from
healthy individuals. Indeed, the performance of the classiﬁers has
been consistently high, with several studies reporting accuracies
above 95% for binary classiﬁcations between patients and con-
trols (Deshpande et al., 2015; Hosseini-Asl et al., 2016; Payan and
Montana, 2015; Sarraf and Toﬁghi, 2016; Suk and Shen, 2013; Suk
et al., 2015a; Suk et al., 2015b). Nevertheless, the application of
a supervised model for diagnostic classiﬁcation is arguably cir-
cular: since diagnostic labels in the training and testing datasets
are predetermined through clinical examination, logic dictates that
a perfect performance from an ML  algorithm will simply mimic
clinical assessment. Being able to predict a future diagnosis, or
anticipate who  will and will not beneﬁt from a certain treatment,
are questions of greater translational value in clinical practice. A
total of 8 studies have applied DL to neuroimaging data acquired
from individuals with MCI  to predict subsequent transition to AD
with promising results. For example, Suk et al. (2015a) success-
fully predicted conversion from MCI  to AD with 83.3% accuracy,
after combining structural MRI  and PET data. However, no studies
have yet examined transition to illness in other psychiatric dis-
orders with a prodromal phase, such as psychosis, even though
we know that it is possible to distinguish between converters and
non-converters using conventional ML  (Zarogianni et al., 2013;
Pettersson-Yeo et al., 2013; Valli et al., 2016). To our knowledge
only one study has used DL to predict treatment outcome. Munsell
et al. (2015) achieved an accuracy of 57% when classifying TLE
patients who  did and did not suffer from seizures after surgi-
cal intervention. As discussed earlier, however, this modest result
could potentially be explained by the absence of formal strategies
to avoid overﬁtting of the DL model.
DL is a very ﬂexible approach, meaning that is it possible to
combine different architectures and manipulate a range of hyper-
parameters within the same model. In addition, the vast majority
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of existing studies have been published in the last 2 years, and
therefore the ﬁeld of DL applied to neuroimaging of brain-disorders
should be considered still at a very early stage. Possibly as a result of
this combination of ﬂexibility and novelty, the methodology of the
studies reviewed in this article varied considerably. For example,
some studies employed a whole-brain approach whereas others
focussed on a subset of regions of interest; some studies used the
raw data without any form of feature selection whereas others per-
formed a number of transformations on the data to select relevant
features; and different studies used different DL architectures. Such
methodological variability means that, at present, the reliability
and replicability of the existing results remain unclear.
4.2. The promise of convolutional neural networks
CNNs are a particular type of feedforward neural network
inspired by how the human visual cortex process information.
Over the past decade, CNNs have been breaking records in com-
puter vision across several competitions, making this approach
a very promising one (Krizhevsky et al., 2012). Consistent with
this, our review has shown that CNNs have generated the most
encouraging results in the context of neuroimaging. In its raw
form, neuroimaging data comprises millions of voxels. Consid-
ering the current computational resources available, putting all
voxel intensities through a fully connected network would lead
to an unfeasible number of weights to be estimated. Two intrin-
sic properties of CNNs – weight sharing and local connectivity
– result in a signiﬁcantly reduced number of weights, making it
computationally possible to run the network at the voxel-level.
Although in neuroimaging CNNs have only been used to exam-
ine MCI  and AD patients, the accuracies of the studies published
so far have been consistently high (i.e. ≥95% for AD and ≥86% for
MCI  versus controls). High accuracies have been observed with
different modalities including structural MRI  (Gupta et al., 2013;
Hosseini-Asl et al., 2016; Payan and Montana, 2015), resting-state
fMRI (Sarraf and Toﬁghi, 2016) and CT imaging (Gao and Hui, 2016),
as well as with small (Gao and Hui, 2016; Sarraf and Toﬁghi, 2016)
and large (Gupta et al., 2013; Hosseini-Asl et al., 2016; Payan and
Montana, 2015) sample sizes. Hosseini-Asl et al. (2016) used an
alternative and interesting approach which involved pre-training
a CNN in one Alzheimer’s dataset (CADDementia) and then ﬁne-
tuning and testing it in another dataset from the same diagnostic
group (ADNI). The results were very promising for both 2-way and
3-way classiﬁcations (HC vs. AD; HC vs. MCI; AD vs. MCI; and HC
vs. AD vs. MCI), although it should be noted that the ADNI sam-
ple was of modest size. Taken together, these results are in line
with the successful performances of CNN-based models reported
in other scientiﬁc areas, and highlight CNNs as a promising tool in
neuroimaging.
4.3. From binary to multiclass classiﬁcations
In the context of neuroimaging, the vast majority of conven-
tional ML  studies have relied on binary classiﬁcations involving the
comparison between a group of patients and a group of healthy con-
trols (Orrù et al., 2012; Wolfers et al., 2015). This can be explained
by the fact that these studies have typically employed SVM, which
was originally designed for binary classiﬁcation problems (Hsu and
Lin, 2002). However, the real challenge for clinicians is not to differ-
entiate between patients and controls but to develop biomarkers
which could be used to choose amongst alternative diagnoses or
different stages of illness progression. Looking forward, therefore,
ML  models will need to be able to discriminate amongst several
possible alternatives in order to inform real-world clinical decision
making. Many approaches have been proposed to enable SVM to
handle multiclass classiﬁcation problems (Fei and Liu, 2006; Hsu
and Lin, 2002). However, this is still an active research area (Kumar
and Gopal, 2011) and none of the proposed approaches have been
tested in the context of neuroimaging. Most neuroimaging studies
using SVM addressed the multiclass problem by performing sev-
eral binary classiﬁcations (for example, AD vs. HC, MCI vs. HC and
AD vs. MCI) or one-against-all classiﬁcations (for example, AD vs.
MCI  & HC and MCI  vs. AD & HC). DL however, requires less techni-
cal effort to perform multiclass comparisons, and therefore could
provide a solution to this issue. This is mainly due to the use of
the so-called softmax function in the output layer, which can be
considered an extension of the binary logistic regression to sev-
eral classes. Here the output reﬂects the probability of belonging
to each class, which is a more intuitive index of class membership
than some of the most sophisticated indices being developed for
SVM multiclass solutions (Fei and Liu, 2006). In light of its suit-
ability for multiclass classiﬁcation, a number of studies have used
DL to carry out 3 or 4-way classiﬁcations between different dis-
order subtypes or different stages of illness. For example, three of
these studies were able to classify children into healthy controls
and three ADHD subtypes (inattentive, hyperactive and combined)
(Hao et al., 2015; Kuang and He, 2014; Kuang et al., 2014). Notably,
there is also preliminary evidence for the use of DL to distinguish
between individuals at no imminent risk of dementia, those identi-
ﬁed at risk who  will and will not develop dementia, and those with
established Alzheimer’s disease (Liu et al., 2015a; Liu et al., 2014;
Suk et al., 2015b). These are encouraging ﬁndings, as they highlight
how DL could help bridge the existing gap between neuroimaging
ﬁndings and real-world clinical practice.
4.4. Is deep learning superior to conventional machine learning?
Despite the success of DL in several scientiﬁc areas, the supe-
riority of this analytical approach in neuroimaging is yet to be
demonstrated. On the one hand, DL has been described as a poten-
tially more powerful approach than conventional shallow ML, as it
is capable of learning highly intricate and abstract patterns from the
data, which can particularly useful in the case of brain-based disor-
ders (Plis et al., 2014). On the other hand, given that neuroimaging
data is very high-dimensional, the nonlinear approach of DL  might
not be advantageous as there are not enough data points to extract
meaningful nonlinear patterns from the data, whereas the linear
approach employed in conventional shallow ML  might be more
appropriate. Here we tried to clarify this issue by systematically
examining the difference in performance between DL and conven-
tional shallow ML  in studies which used both approaches. A total
of twenty-ﬁve studies reported classiﬁcation accuracy for both DL
and conventional shallow ML,  with the latter being a kernel-based
method, either SVM or MKL. For the majority of these studies DL
performed better than conventional shallow ML  as shown in Fig. 5,
and in some cases the difference was  by a reasonable margin (e.g.
Han et al., 2015; Plis et al., 2014; Suk and Chen, 2013).
From the available evidence, it is not clear whether DL tends to
perform better under speciﬁc circumstances, for example depend-
ing on the modality type or the sample size. However, our
systematic review provides anecdotal evidence that studies com-
bining imaging and non-imaging data tend to have a larger margin
in favour of DL (see Fig. 6). This is consistent with the notion that
the association between brain abnormalities and cognitive symp-
toms, for example, is likely to exist at a deep and abstract level,
and as such can be captured more effectively by DL methods than
traditional shallow ML  methods (Plis et al., 2014).
We know that the application of traditional shallow ML  methods
to neuroimaging data leads to higher and more stable accuracies
as the sample size increases (Nieuwenhuis et al., 2012). One  would
expect this to be especially true for DL: since a deep model is inher-
ently more complex than conventional shallow ML  models, larger
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sample sizes should be needed to compensate for the greater num-
ber of parameters to be estimated and to take full advantage of
DL’s ability to detect highly intricate and abstract patterns in the
data. We  were therefore expecting to see an increase in the mar-
gin by which DL outperforms kernel-based methods as sample sizes
increase. Such increase however was not observed, as the pattern of
difference in performance did not seem to vary systematically with
sample size; one possibility is that larger sample sizes than those
used in the existing literature would be required to detect increases
in the margin by which DL outperforms kernel-based methods.
In conclusion, our review suggests that, overall, DL performs
better than conventional shallow ML.  In light of the increasing
interest in DL, however, we cannot exclude a publication bias which
favoured studies showing the superiority of this new analytical
approach relative to conventional shallow ML  methods (Boulesteix
et al., 2013). As the number of studies applying DL to neuroimaging
data increases, a thorough assessment of publication bias would be
useful to establish the reliability of this initial trend in favour of DL.
4.5. Interpretability of DL in neuroimaging
Despite having demonstrated state-of-the-art performances
across several ﬁelds, DL has been under scrutiny for its lack of
transparency during the learning and testing processes (Alain and
Bengio, 2016; Lou et al., 2012; Yosinski et al., 2015). For example,
deep neural networks have been referred to as a “black box” in
contrast with other techniques, such as logistic regression, which
are less complex and more intuitive. Such lack of transparency has
important implications for the interpretability of the results when
DL is applied to neuroimaging data. Due to the multiple nonlineari-
ties, it can be challenging to trace the consecutive layers of weights
back to the original brain image in order to identify which features
(e.g. regions) are providing the greatest contribution to classiﬁca-
tion (Suk et al., 2015a). This information however would be useful
in the context of clinical neuroimaging where the aim is not only to
detect but also localise abnormalities. A ﬁrst potential issue is that a
model with an excellent performance may  be using irrelevant fea-
tures (e.g. orientation of the images, imaging artefacts), as oppose
to clinically meaningful information (e.g. regional grey matter, con-
nectivity between different brain regions), to classify participants. A
second potential issue is that an accurate model which provides no
information about the underlying neuroanatomical or neurofunc-
tional alterations would be of limited clinical utility, for example
with respect to treatment development and optimization.
Despite its complex inner workings which make the visualiza-
tion and interpretation of the weights challenging, DL can be used
in a way which enables transparency. This is illustrated by several
neuroimaging studies included in this review that did report the
most important features (e.g., Deshpande et al., 2015; Kim et al.,
2016; Liu et al., 2014; Suk et al., 2016). However, these studies
used a variety of approaches to isolate the most informative fea-
tures, and at present there is no standard and intuitive method
for visualizing weights or interpreting latent feature representa-
tions (Suk et al., 2015a). This has motivated several attempts to
develop new and intuitive ways of enhancing the interpretability
of DL within the recent literature (e.g., Grün et al., 2016; Samek
et al., 2015; Simonyan et al., 2013; Yosinski et al., 2015; Zeiler
and Fergus, 2014). There are two main methodological approaches
to address this issue, including input modiﬁcation methods and
deconvolution methods. Input modiﬁcation methods are visual-
ization techniques that involve the systematic modiﬁcation of the
input and the measurement of any resulting changes in the output
as well as in the activation of the artiﬁcial neurons in the inter-
mediate layers of the network. An example of these methods is
the so-called occlusion method (Zeiler and Fergus, 2013) which
involves covering portions of the input image up to ﬁnd the areas of
the input data that inﬂuence the probability of the output classes.
In contrast, deconvolution methods aim to determine the contri-
bution of one or more features of the input data to the output. This
involves selecting an activation of interest in an output neuron and
then computing the contribution of each neuron in the next lower
layers to this activation. Here a number of strategies are available
to model the nonlinearities present across the layers, for example,
deconvnet (Zeiler and Fergus, 2013) and guided backpropagation
(Springenberg et al., 2014).
4.6. The challenge of overﬁtting
Overﬁtting is arguably one of the main challenges in ML.  Given
their inherent complexity, DL networks are particularly prone to
overﬁtting, i.e., learning irrelevant ﬂuctuations in the data that limit
generalizability. Not surprisingly, different approaches to address
this issue, known as regularization strategies, have been developed
and are now present in most DL algorithms. In section 2.1.4 we
described some of the most commonly used regularization strate-
gies applied to modern DL, namely weight decays and dropout. As
expected, several studies reviewed here have used some form of
regularization. The majority (e.g., Hosseini-Asl et al., 2016; Kim
et al., 2016; Liu et al., 2015a) have employed the L1 or L2 norms,
which prevent overﬁtting by penalizing very low or very high
weight values. At least one study (Li et al., 2014) employed dropout,
where a random number of nodes and respective connections are
temporarily removed to extract different sets of features that can
independently produce a useful output. The importance of regu-
larization strategies in DL could potentially account for the fact
that Munsell and colleagues, who trained 4- and 5-hidden layer
models (for inferring diagnostic and treatment outcome, respec-
tively) without using any form of regularization, reported such low
performance for DL (Munsell et al., 2015).
An additional approach for minimising the risk of overﬁtting
involves reducing the dimensionality of the data before inputting
them into the model. A possible way  of achieving this is by extract-
ing region- or patch-level features (as opposed to using voxel-level
data). Using different types of features (whether voxel, patch or
region) can have implications for how detailed the information
inputted into the model is (for example, voxel-level features are
very detailed, and also very noisy; region-level features on the
other hand, ignore more localized patterns and are less sensitiv-
ity to noise). Another option to reduce dimensionality is feature
selection. Feature selection is common in conventional ML, where
linear methods such as principal component analysis, independent
component analysis or elastic net, are used to select the most dis-
criminating features that are then fed to a classiﬁer. However, the
use of conventional feature selection methods prior to a DL model
seems counterintuitive, since one of the main advantages of DL is
the ability to learn, through a purely data-driven method, the most
useful features for classiﬁcation. Several studies reported in this
review have attempted to reduce the dimensionality of the data
by extracting region- or patch-level features, using feature selec-
tion, or combining the two approaches. We  note, however, that all
CNN-based models were applied to voxel-level data without being
preceded by any form of feature selection and yet reported consis-
tently high performances on unseen data. This suggests that DL, and
CNN-models and particular, can perform well with neuroimaging
data without the requirement to downsize or even preprocess the
data. For example, Hosseini-Asl et al. (2016) achieved high levels of
accuracy after applying a CNN to voxel-level data without any pre-
processing or even skull stripping of the images. This ﬁnding has
potential implications for the development of clinical tools, as it
suggests that it might be possible to apply DL to raw neuroimaging
data, thereby saving time as well as technical resources.
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4.7. Technical expertise and computational requirements
The studies reviewed in this article employed a wide range of DL
architectures and hyperparameters. Such ﬂexibility is what makes
DL a very powerful tool but comes at a potentially high cost. The
number of layers, the number of nodes within each layer and the
activation function of each node are only a few examples of a long
list of variables one has to consider when designing and optimizing
a DL model. Automated optimization strategies are not yet widely
available, making optimisation a manual process that requires a
great deal of technical expertise and is potentially prone to subjec-
tive bias. Since the number of parameters to be estimated is very
large, the computational requirements of DL are also more demand-
ing than those of conventional ML  methods. For example, Kim et al.
(2016) reported that the estimation of a DL model with three hidden
layers took 100 times longer than the estimation of a standard SVM
model (∼3.3 days vs. 0.8 h). However, with the fast-growing avail-
ability of graphical processing units (GPUs), the application of DL to
neuroimaging data is likely to become less and less time-consuming
in the future.
5. Conclusions and future directions
While still in its initial stages, the application of DL in neu-
roimaging has shown promising results and has the potential of
leading to fundamental advances in the search for imaging-based
biomarkers of psychiatric and neurologic disorders. Nevertheless,
several improvements will be required before the full potential of
DL in neuroimaging can be achieved. Firstly, given the complex-
ity of DL models, we need to move away from studies with small
to modest sample sizes in favour of much larger cohorts. A pos-
sible way of achieving this is through multi-centre collaborations,
in which data is collected using the same recruitment criteria and
scanning protocols across sites. A further way of increasing the sam-
ple size is through multi-site data sharing initiatives, such as ADNI
for Alzheimer’s disease and ADHD-200 for ADHD. Secondly, the
integration of CNN and recurrent neural networks (i.e. networks
that allow the processing of data with sequential inputs such as
videos or speech) is likely to lead to signiﬁcant advances in DL in
the next few years (Donahue et al., 2015). In neuroimaging, this
integration could be particularly useful for analysing fMRI data, as it
would allow the detection of intricate spatial patterns while simul-
taneously modelling the temporal component of the BOLD signal.
Thirdly, we anticipate that an increasing number of neuroimag-
ing studies will make use of transfer learning, which involves
using previously learned features from a large sample of similar
enough images. This could help tackle the curse of dimensionality
− a common problem in neuroimaging studies of brain disor-
ders (Gupta et al., 2013; Hosseini-Asl et al., 2016). Evidence from
vision science, where deeper models such as VGG net (Simonyan
and Zisserman, 2014), residuals networks (He et al., 2015) and
Inception-v4 (Szegedy et al., 2016) are achieving the highest perfor-
mances, suggests that transfer learning could be particularly useful
when deeper models are employed. Fourthly, we  suggest that the
so-called augmentation technique – which it is commonly used in
computer vision – could be useful in the context of neuroimag-
ing. This technique involves increasing the sample size by applying
transformations to the data (e.g., rotation, shear, scaling), and then
train a model that is invariant to such transformations. The use
of augmentation could also address the issue of modest sample
sizes and lead to a decrease in prepossessing time (because steps
such as rotation may  become redundant). Finally, the use of DL to
predict continuous scores is another interesting area for further
research with potential clinical applicability, following the encour-
aging results obtained using conventional ML  methods (e.g. Gong
et al., 2014; Stonnington et al., 2010; Tognin et al., 2014). So far,
only one study has used DL to predict clinical scores from struc-
tural MRI  scans in patients with Alzheimer’s disease (Brosch and
Tam, 2013).
In conclusion, the capacity of DL models to learn complex
and abstract representations through nonlinear transformations,
makes this a promising approach to single subject prediction in
neuroimaging. While there are still important challenges to over-
come, the ﬁndings reviewed here provide preliminary evidence
supporting the potential role of DL in the future development of
diagnostic and prognostic biomarkers of psychiatric and neurologic
disorders.
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